Used in the pharmaceutical industry as an intermediate in the synthesis of certain central nervous system (CNS) active compounds, particularly those targeting neurological and psychiatric disorders. Its structure supports the development of agents with potential antidepressant, anxiolytic, or cognitive-enhancing effects. The compound’s stereochemistry makes it valuable for creating enantiomerically pure drugs, improving efficacy and reducing side effects. It is primarily utilized in research and early-stage drug development for neurodegenerative diseases and mood disorders.